«The Anglo-Swedish pharmaceutical giant AstraZeneca will open a research and development hub in Barcelona to develop new therapies, creating 1,000 new jobs in the next five years. With this in mind, the company will invest €800 million in its new European hub based in the Catalan capital»

«The new hub will coordinate international projects in five different areas such as oncology; cardiovascular, renal, and metabolism; respiratory diseases and immunology; vaccines and immunotherapies; and rare diseases.»

«With all the technological and professional resources specialized in the investigation, the hub intends to become one of the most important in Europe for its «excellence in clinical innovation.»

Article written by Aina Martí



Catalan News